DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Selegiline for Smoking Cessation - 1

Phase 2

Completed

Conditions: Nicotine Dependence

Interventions: Drug: Selegiline Transdermal Patch
Drug: Placebo
Behavioral: Smoking Cessation Counseling

First Posted Date: 2007-02-23

Last Posted Date: 2017-02-02

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 246

Registration Number: NCT00439413

Locations: 🇺🇸
Department of Public & Community Health, College Park, Maryland, United States
🇺🇸
Tri-State Tobacco and Alcohol Research Center, Cincinnati, Ohio, United States
🇺🇸
Center For Tobacco Research and Intervention, Milwaukee, Wisconsin, United States

and more 1 locations

Ph1 Lobeline Interaction Study - 1

Phase 1

Conditions: Methamphetamine Dependence

First Posted Date: 2007-02-23

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 10

Registration Number: NCT00439504

Locations: 🇺🇸
Langley Porter Psychiatric Institute, San Francisco, California, United States

Ph1 Marinol Interaction Study - Part 1 - 1

Phase 1

Terminated

Conditions: Marijuana Dependence

First Posted Date: 2007-02-21

Last Posted Date: 2017-01-16

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 6

Registration Number: NCT00438139

Locations: 🇺🇸
Uniformed Services University of Health Science, Bethesda, Maryland, United States

Human Factors Analysis in VR for Burn Treatment

Phase 1

Completed

Conditions: Pain
Chronic Pain

Interventions: Behavioral: Virtual Reality based distraction
Behavioral: VR with flat projection display
Behavioral: non-interactive video with head display
Behavioral: non-interactive video with with flat projection display

First Posted Date: 2006-12-11

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 10

Registration Number: NCT00409552

Study to Reduce Intravenous Exposures (STRIVE)

Phase 2

Completed

Conditions: HIV Infections
Hepatitis C

First Posted Date: 2006-10-24

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 750

Registration Number: NCT00391482

Locations: 🇺🇸
Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, United States
🇺🇸
Public Health Seattle & King County, Seattle, Washington, United States
🇺🇸
New York Academy of Medicine, Center for Urban Epidemiologic Studies, New York, New York, United States

Topiramate for the Treatment of Methamphetamine Dependence - 1

Phase 2

Completed

Conditions: Methamphetamine

Interventions: Drug: Placebo Oral Tablet
Drug: Topiramate

First Posted Date: 2006-06-28

Last Posted Date: 2017-03-27

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 140

Registration Number: NCT00345371

Locations: 🇺🇸
Matrix Institute on Addictions, Costa Mesa, California, United States
🇺🇸
John A. Burns School of Medicine, Honolulu, Hawaii, United States
🇺🇸
University of Missouri - Kansas City, Kansas City, Missouri, United States

and more 5 locations

Hyperalgesia in Methadone Patients: Can it be Treated?

Phase 1

Conditions: Opioid-induced Hyperalgesia

First Posted Date: 2006-06-02

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 40

Registration Number: NCT00333242

Locations: 🇺🇸
UCLA School of Nursing, Los Angeles, California, United States

Randomized Trial of the Positive Action Program in Hawaii Schools

Not Applicable

Completed

Conditions: Character
Violence
Pro-social Behavior
Substance Use
Academic Achievement

Interventions: Behavioral: Positive Action

First Posted Date: 2006-05-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 2500

Registration Number: NCT00328445

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
Oregon State University, Corvallis, Oregon, United States
🇺🇸
Positive Action, Inc., Twin Falls, Idaho, United States

Effects of Buspirone in Opiate Withdrawal

Phase 4

Completed

Conditions: Heroin Dependence

First Posted Date: 2006-05-16

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Registration Number: NCT00326235

Locations: 🇺🇸
VA New York Harbor Healthcare System - Brooklyn Campus, Brooklyn, New York, United States

Effect of Clonidine on Responses to Imagery Scripts

Phase 1

Completed

Conditions: Cocaine Abuse
Heroin Abuse

Interventions: Drug: Placebo
Drug: Clonidine

First Posted Date: 2006-04-27

Last Posted Date: 2018-04-05

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 92

Registration Number: NCT00318760

Locations: 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy